In partnership with

Hello {{first_name | AI enthusiast}},

The de-identified clinical data deal from OneMedNet, RelativityOne’s Copilot integration, and UNC’s rare-disease AI data push put healthcare, legal, and enterprise automation on a collision course. Meanwhile, Onos Health’s $17 million raise and StoreClaw’s holiday AI data show where capital and urgency are flowing next. Scroll down to catch the signals that matter

How Jennifer Aniston’s LolaVie brand grew sales 40% with CTV ads

For its first CTV campaign, Jennifer Aniston’s DTC haircare brand LolaVie had a few non-negotiables. The campaign had to be simple. It had to demonstrate measurable impact. And it had to be full-funnel.

LolaVie used Roku Ads Manager to test and optimize creatives — reaching millions of potential customers at all stages of their purchase journeys. Roku Ads Manager helped the brand convey LolaVie’s playful voice while helping drive omnichannel sales across both ecommerce and retail touchpoints.

The campaign included an Action Ad overlay that let viewers shop directly from their TVs by clicking OK on their Roku remote. This guided them to the website to buy LolaVie products.

Discover how Roku Ads Manager helped LolaVie drive big sales and customer growth with self-serve TV ads.

The DTC beauty category is crowded. To break through, Jennifer Aniston’s brand LolaVie, worked with Roku Ads Manager to easily set up, test, and optimize CTV ad creatives. The campaign helped drive a big lift in sales and customer growth, helping LolaVie break through in the crowded beauty category.

🧬 OneMedNet’s data deal targets faster drug AI

OneMedNet is deepening its role in drug discovery by supplying de-identified real-world clinical data for AI model development, giving biopharma teams richer evidence to train systems that can spot patterns faster and support earlier decisions. The move underscores how data access is becoming a competitive edge in AI-driven drug development.

The race now hinges on who can combine compliant data access with usable clinical insight.

10x the context. Half the time.

Speak your prompts into ChatGPT or Claude and get detailed, paste-ready input that actually gives you useful output. Wispr Flow captures what you'd cut when typing. Free on Mac, Windows, and iPhone.

⚖️ Chatbot logs are entering the courtroom

Civil and criminal cases are increasingly pulling in AI chatbot conversation logs, including ChatGPT exchanges, as evidence, forcing lawyers to confront new questions about privilege, privacy, and discoverability. As people use chatbots for sensitive advice, the legal system is being pushed to define whether those prompts and outputs should be treated like protected communications or searchable records.

Expect tighter policies around what employees, clients, and defendants put into AI tools.

🤖 RelativityOne plugs into Microsoft Copilot

RelativityOne is extending legal data intelligence through a Microsoft Copilot integration built on the Model Context Protocol, aiming to automate research, review, and workflow steps inside legal operations. By connecting enterprise AI to structured legal data, the platform signals a shift from isolated copilots to governed, task-specific automation.

Legal teams will increasingly demand AI that works inside their existing systems, not beside them.

🏭 Express LUCK brings edge AI to the factory floor

Express LUCK has deployed a MemryX-powered edge AI system to monitor production lines in real time and improve safety compliance without relying on cloud latency. The setup reflects a broader manufacturing push toward on-site inference, where speed, reliability, and immediate action matter more than distant analytics dashboards.

Factory AI is moving closer to the machines it supervises.

Creators lock in holiday calendars 90 days out. Structure commissions, recruit creators, and optimize your creator affiliate strategy before the rush with Levanta's 90-Day Holiday Sprint. Get the Free Guide.

💼 PlanAdviser spotlights a wave of AI launches

PlanAdviser highlighted a string of AI launches spanning a financial services practice, CRM tooling, and security automation, showing how advisors and vendors are packaging AI into practical workflow products rather than abstract experimentation. The trend suggests buyers want targeted tools that improve prospecting, service delivery, and risk control inside day-to-day operations.

The next buyer question is not whether AI exists, but whether it saves time immediately.

🧠 Onos Health raises $17 million for behavioral health AI

Onos Health secured a US$17 million Series A to scale an AI platform that analyzes claims and clinical data for behavioral health quality, a niche where administrative complexity often obscures care gaps. The funding signals investor confidence in tools that can translate fragmented records into measurable performance and reimbursement insight.

Behavioral health analytics is becoming a serious venture category, not a side project.

🏥 EHR AI draws fresh venture attention

BCC Research says AI is transforming electronic health records while venture capital into the space surpassed US$1 billion, a sign that investors see major upside in reducing documentation drag and improving clinical usability. The report frames EHR modernization as a core AI battleground where workflow efficiency and data quality could determine adoption.

Venture money is chasing the software layer that clinicians use every hour.

💬 Valify turns spend analysis into a chat experience

Valify launched Valify AI Chat, a conversational and context-aware tool designed to help healthcare organizations interrogate complex spend data more naturally. Instead of forcing teams through static reports, the product lets users ask questions in plain language and drill into cost patterns, sourcing issues, and savings opportunities faster.

Natural-language analytics is becoming the front door to enterprise finance data.

🧪 UNC and Emory land $35 million for rare-disease AI data

UNC School of Medicine and Emory University won up to US$35 million from ARPA-H to build a rare-disease data resource aimed at improving AI diagnostics. The initiative could help researchers train models on harder-to-find cases, where fragmented evidence has long limited early detection and accurate classification.

Rare-disease AI will depend on whether high-quality data can finally be assembled at scale.

🛒 StoreClaw says sellers are gearing up early for Q4

StoreClaw says e-commerce sellers are increasingly using its AI growth engine to prepare ahead of the holiday rush, reflecting a shift from reactive merchandising to proactive forecasting and campaign planning. The data points to a retail environment where AI is becoming a preseason weapon for inventory, pricing, and conversion strategy.

Holiday winners will be the sellers who let AI plan before demand spikes.


Which story surprised you today? A one-line reply is enough.

Help a colleague stay ahead: share your referral link

Reply

Avatar

or to participate